Mandate

Vinge advises FAM in connection with the restructuring of Bergvik Skog and the formation of Kopparfors Skogar

May 31, 2019

FAM and other shareholders in Bergvik Skog AB have performed a restructuring of the ownership of Bergvik Skog whereupon, among other things, Bergvik Skog Väst AB has been divided up and one of FAM wholly‑owned subsidiaries, Kopparfors Skogar AB, has acquired through a subsidiary approximately 283 000 hectares of land in central Sweden. 

FAM was advised by Vinge, the team of which primarily consisted of Jonas Johansson, Joacim Rydergård, Carl Sander and Jesper Lindvall (Corporate/M&A), Assur Badur and Karolina Cohrs (Real Estate), Thomas Sjöberg (Environmental), Louise Brorsson Salomon (Financing) and Johan Wahlbom (Competition Law).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026